Yahoo Finance

Aldeyra Therapeutics Receives Special Protocol Assessment Agreement Letter from the U.S. Food and Drug Administration for ADX-2191 for the Treatment of Primary Vitreoretinal ...

LEXINGTON, Mass., June 26, 2025--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced receipt of ...
Yahoo Finance

China Medical System: NDA for Additional Rheumatoid Arthritis Indication of Methotrexate Injection Approved in China

SHENZHEN, CHINA, Aug. 05, 2024 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the “Company”, together with its ...
Pharmabiz

Aldeyra Therapeutics gets US FDA’s special protocol assessment agreement letter for its drug candidate, ADX-2191 to treat primary vitreoretinal lymphoma

Aldeyra Therapeutics, Inc, a biotechnology company devoted to discovering innovative therapies designed to treat immune-mediated ...
Everyday Health via MSN

10 tips for making RA self-injections easier

With training and planning, self-injecting your rheumatoid arthritis medication may be easier than you think.
Business Wire

Data from the MIRROR Randomized Controlled Trial of KRYSTEXXA ® (pegloticase) Injection with Methotrexate Published in Arthritis & Rheumatology

-- Month 6 data showed a greater than 30 percentage-point increase in efficacy, and a significant reduction in infusion reactions ...
Finanznachrichten

China Medical System Holdings Ltd.: NDA for Additional Rheumatoid Arthritis Indication of Methotrexate Injection Approved in China

Methotrexate is recognized internationally as the first choice first-line and anchor drug for RA. The Product is the first methotrexate prefilled injection to treat RA by subcutaneous administration ...